FDA To Review Contractor Workforce In Broad Staffing Assessment
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's budgeting and prioritization efforts are more difficult because it does not know how much it spends on contractors, GAO notes.
You may also be interested in...
FDA's No-Bid Contracts Could Be Further Reduced, Even With Recent Progress
Agency now awarding 80 percent of eligible contracts competitively.
FDA's No-Bid Contracts Could Be Further Reduced, Even With Recent Progress
Agency now awarding 80 percent of eligible contracts competitively.
FDA's DTC Review Problems Highlight Industry's Growing Legal Squeeze
The Government Accountability Office's report on FDA's staffing and budgeting problems highlights the agency's funding challenge: it's so strapped that it often can't even effectively assess how it's using its resources